Biovie BIVI
NASDAQ BIVI
$1.46 -0.01 (-0.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biovie (BIVI) Non Operating Interest Expenses (2017 - 2026)

Updated

Biovie's Non Operating Interest Expenses was $3,978 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 20.4% from $4,998 a year earlier and down 33.3% from the prior quarter.

Analysis

Biovie (BIVI) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Non Operating Interest Expenses at Biovie came in at $17,901, down 94.6% from FY2025.

  • Non Operating Interest Expenses has now declined for three consecutive fiscal years, with a five-year compound annual growth rate of -49.8% (FY2021 to FY2026).
  • In earlier fiscal years, Non Operating Interest Expenses was $332,720 in FY2025 (-88.5%), $2.89 million in FY2024 (-32.7%), $4.3 million in FY2023 (+95.5%) and $2.2 million in FY2022 (+293.2%).
  • Quarterly Non Operating Interest Expenses has moved between $1,114 (fiscal Q1 2022) and $1.1 million (fiscal Q4 2023) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in 1 of the last eight quarters, with an average decline of 69.5%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was fiscal Q2 2023 (growth of 247.8%); the worst was fiscal Q1 2022 (a decline of 99.8%).
  • Per Business Quant data, BIVI's Non Operating Interest Expenses in the three fiscal quarters before Q4 2026 was $5,967 (Q3 2026), $5,967 (Q2 2026) and $1,989 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Biovie 11.09 Mn 11.09 Mn - 3,978.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,978.00
Mar 31, 2026 5,967.00
Dec 31, 2025 5,967.00
Sep 30, 2025 1,989.00
Jun 30, 2025 4,998.00
Mar 31, 2025 4,998.00
Dec 31, 2024 66,700.00
Sep 30, 2024 256,024.00
Jun 30, 2024 439,943.00
Mar 31, 2024 628,711.00
Dec 31, 2023 820,600.00
Sep 30, 2023 1.00 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.10 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 963,990.00
Mar 31, 2022 919,000.00
Dec 31, 2021 316,263.00
Sep 30, 2021 1,114.00
API Access

Biovie Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BIVI&period=max&api_key=YOUR_API_KEY